SUPN

Supernus Pharmaceuticals, Inc. $41.64 1M -13.0% 3M -8.6% YTD -15.8% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.4%
Next 1 week
+1.4%
Next 1 month
-0.8%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -5.7% median, 31% of the last 13 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 1
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.32%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.44 -0.1% · Seasonal tilt -0.8%
$25M/day volume 36% volatility -10% 1-year -32% from ATH
52-week range · 3% of the way up · -30% from the high
$41.11$59.68

Congressional trades in SUPN Full tracker →

2 members · 7 buys / 2 sells · $9K–$135K disclosed · latest filing Apr 7, 2026.

BUY GC Gilbert Cisneros · traded Mar 3, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Dec 11, 2025 $1K–$15K
SELL GC Gilbert Cisneros · traded Oct 9, 2025 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 24, 2025 $1K–$15K
SELL JG Josh Gottheimer · traded Dec 23, 2022 $1K–$15K
BUY GC Gilbert Cisneros · traded Nov 13, 2020 $1K–$15K
BUY GC Gilbert Cisneros · traded Jul 17, 2020 $1K–$15K
BUY GC Gilbert Cisneros · traded Jun 1, 2020 $1K–$15K

Earnings Full history →

Next report 2026-11-03 (Tuesday, before open, in 50 days) · EPS est. 0.62.

1-day std dev
9.3%
Finished up
59%
Biggest pop
+23.8%
Biggest drop
-31.6%

Standard deviation of the close-to-close move over the last 58 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.